PX-12

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePX-12
Drug Alias NameMIDIV-2-compoundthioredoxin-1 inhibitor PX-12thioredoxin inhibitor PX-12PX-12 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThioredoxin reductase inhibitors
TargetsThioredoxin reductase
Therapy Area/IndicationsNeoplasm MetastasisPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCascadian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCascadian Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisPancreatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank